| Generic Name | Brand Name |
|---|---|
| dexmethylphenidate | Focalin |
| dextroamphetamine | Dexedrine, Dextroamphetamine, Dextrostat |
| lisdexamfetamine | Vyvanse |
| methylphenidate | Concerta, Daytrana, Metadate CD, Methylin, Ritalin |
| mixed salts amphetamine | Adderall |
Stimulants affect how the brain controls impulses and regulates behavior and attention. They do this by influencing the availability of certain chemicals, called neurotransmitters, in the brain.
Stimulants are considered for people with moderate to severe attention deficit hyperactivity disorder (ADHD) who have difficulty in at least two different settings, such as school and home.3 Stimulant medicines with amphetamine, such as Adderall, that are used for the treatment of ADHD are approved by the U.S. Food and Drug Administration (FDA) for children age 3 and older. Stimulant medicines with methylphenidate, such as Ritalin, are approved for children age 6 and older. A doctor may prescribe Ritalin for a child under age 6 based on the child's specific needs.
Stimulants may be used in people with ADHD who also have mood disorders, such as depression. The priority of which condition is treated first usually depends on which is thought to be the main disorder.
Stimulants may be used in adults when antidepressants fail to control ADHD symptoms. If antidepressants alone are not controlling symptoms, stimulants may be added.
Stimulants may be the most effective treatment for the symptoms of ADHD: inattention, impulsivity, and hyperactivity. These medicines can suddenly and dramatically improve behavior. But some people need to try different types and dosages of stimulants to find the one that works best for them. If treatment with a stimulant is successful, it usually helps control symptoms over time without increasing the dosage.3
In about 70% of people with ADHD, stimulant medicines improve symptoms.3
Children often become calmer, more organized, and less stubborn. Examples of behaviors that improve include:3
Although stimulants may also improve social adjustment or academic performance for some children, they have not been shown to maintain this benefit over the long-term.
One study found that children with ADHD whose symptoms were predominantly related to inattention showed significant improvement when they took lower doses (36 mg or lower) of long-acting methylphenidate (Concerta) and had less benefit from higher doses. In children with ADHD who had symptoms of both hyperactivity and inattention, most showed increased improvement in symptoms when they took higher doses (36 mg to 54 mg). But higher doses resulted in increased insomnia and decreased appetite in both groups of children.2
The most common side effects (affecting about 50% of people) of stimulants are usually related to the dose and go away after the first 2 to 3 weeks on the medicine. Persistent side effects can usually be relieved by changing the dosage level, changing when the medicine is given, or trying a different type of stimulant. The most common side effects include:
Other side effects are also usually temporary or go away with dosage adjustment. These include:
Long-term use of stimulant medicine appears to be safe and effective.4
Stimulant medicines may be related to slower growth in children, especially in the first year of taking the medicine. But most children seem to catch up in height and weight by adulthood. Your doctor will keep track your child's growth and watch for problems.4
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
All medicines approved for the treatment of ADHD come with a U.S. Food and Drug Administration (FDA) warning about possible heart-related or mental problems. Before starting a medicine for ADHD, tell your doctor if your child or you have any heart problems, heart defects, or mental health problems.
Methylphenidate and dextroamphetamine usually take effect within 1 hour after the first dose. Talk to your doctor about the best time to take the medicine.
Treatment with stimulants may be continued as long as the symptoms are present, the medicine continues to work, and there are no significant side effects.
People with ADHD do not tend to abuse stimulant medicine and very rarely develop dependence on (addiction to) on the medicine. Also, there is no evidence that people with ADHD who take stimulants are at greater risk for abusing other drugs. In fact, people who take stimulants for ADHD may be less likely to abuse drugs.1
Some people buy or steal stimulant medicines. Parents need to be certain that their child takes his or her medicine and does not share it with or sell it to anyone else. If this is a concern, talk to your doctor about your child taking a medicine in a safer form.
Canadian health authorities stopped sales of Adderall XR in Canada, but after carefully reviewing the data, the drug was returned to the market. Health Canada withdrew the medicine from the market after learning that Adderall XR and Adderall (sold in the United States, not in Canada) have been linked to 20 sudden deaths and 12 strokes in children and adults in the U.S. After reviewing the Canadian decision and the medical reports, the FDA has not recommended any immediate changes in the FDA labeling or approved use of this drug. The FDA recommends that you talk to your doctor if you have any questions or concerns about using this medicine.5
When stimulants are used to treat ADHD, remember that:
Tips for giving methylphenidate or dextroamphetamine to children:
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Upadhyaya HP (2008). Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: Implications for treatment and the role of the primary care physician. Primary Care Companion Journal of Clinical Psychiatry. 10(3): 211–221.
- Stein MA, et al. (2003). A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 112(5): e404–e413.
- American Academy of Child and Adolescent Psychiatry (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41(2, Suppl): 26S–49S.
- Greenhill LL, Hechtman LI (2009). Attention-deficit/hyperactivity disorder. In BJ Sadock et al., eds., Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 9th ed., vol. 2, pp. 3560–3572. Philadelphia: Lippincott Williams and Wilkins.
- U.S. Food and Drug Administration (2005). FDA Statement: Statement on Adderall. Available online: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108411.htm.
Last Revised: April 12, 2010
Author: Healthwise Staff
Medical Review: John Pope, MD - Pediatrics & Thomas Emmett Francoeur, MD, MDCM, CSPQ, FRCPC - Pediatrics
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Seton is proud to have four hospitals – the only hospitals in Central Texas - that have earned the Magnet designation, the highest award for nursing excellence given by the American Nurses Association.
